ESR1 and breast cancer: One of the most aggressive breast cancer subtypes is triple-negative breast cancer (TNBC), which lacks estrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) amplification [14, 15].